Spatiotemporal Regulation Of Hydrogen Sulfide Signaling in The Kidney
Mar 05, 2022
Contact: tina.xiang@wecistanche.com
A B S T R A C T
Hydrogen sulfide (H2S)has long been recognized as a putrid, toxic gas. However, as a result of intensive biochemical research in the past two decades, H2S is now considered to be the third gasotransmitter alongside nitric oxide (NO) and carbon monoxide(CO)in mammalian systems. H2S-producing enzymes are expressed in all organs, playing an important role in their physiology. In the kidney, H2S is a critical regulator of vascular and cellular function, although the mechanisms that affect(sub)cellular levels of H.S are not precisely understood. H2S modulates systemic and renal blood flow, glomerular filtration rate, and the renin-angiotensin axis through direct inhibition of nitric oxide synthesis. Further, H2S affects cellular function by modulating protein activity via post-translational protein modification: a process termed persulfidation. Persulfidation modulates protein activity, protein localization, and protein-protein interactions. Additionally, acute kidney injury (AKD due to mitochondrial dysfunction, which occurs during hypoxia or ischemia-reperfusion (IR), is attenuated by H2S.H2S enhances ATP production, prevents damage due to free radicals, and regulates endoplasmic reticulum stress during IR. In this review, we discuss current insights in the(sub)cellular regulation of H2S anabolism, retention, and catabolism, with relevance to spatiotemporal regulation of renal H2S levels. Together, H2S is a versatile gasotransmitter with pleiotropic effects on renal function and offers protection against AKI. Unraveling the mechanisms that modulate(sub)cellular signaling of H2S not only expands fundamental insight into the regulation of functional effects mediated by H2S but can also provide novel therapeutic targets to prevent kidney injury due to hypoxic or ischemic injury.
Keywords: Hydrogen sulfide Gasotransmitter Kidney Persulfidation Ischemia-reperfusion injury Hypoxia
1. Introduction
Representing the simplest sulfur-containing molecule, hydrogen sulfide(HS)-also known as sulfane(according to recent nomenclature)[1]-is a flammable colorless gas that has been mainly recognized as a toxic compound. Toxicity occurs already at low concentrations, upon prolonged exposure to concentrations above 2-5 parts per million or acute exposure to 100 parts per million or higher. The major toxicity of H2S occurs through inhibition of mitochondrial cytochrome c oxidase, leading to metabolic acidosis associated with cardiovascular and respiratory collapse and sudden loss of consciousness [2]. Endogenous H2S synthesis in mammalian cells, however, produces much lower, non-toxic concentrations and is recognized to have important physiological functions. H2S is enzymatically synthesized by cystathionine-β-synthase (CBS)[3], cystathionine Y-lyase(CSE), 3-mercaptopyruvate sulfur-transferase (3-MST), and indirectly by p-amino acid oxidase (DAO)[3-5]. Following nitric oxide (NO) and carbon monoxide(CO), H2S was recently recognized as the third gasotransmitter: signaling molecules that can freely diffuse through membranes to transmit information [5-8]. Given the pleiotropic effect of H>S on different critical physio-logical pathways, spatiotemporal regulation of HS is paramount to allow cellular target specificity [9].
H2S plays an important role in renal physiology by modulating renal blood flow, endocrine function, and metabolism. First, the concentration-dependent vasoactive properties of HS are of major influence on renal blood flow [10,11]. In addition, H2S affects renal endocrine function through regulation of renin and angiotensin I receptor levels, and induction of norepinephrine and aldosterone release, as demonstrated in a murine model of heart failure [12]. Further, H2S can attenuate ischemia/reperfusion injury through the reduction of oxidative stress, which is illustrated by the observation that mice lacking either CBS, CSE or 3-MST have a profoundly reduced resistance to ischemia/reperfusion injury in several organs [13-15]. Hence, tight regulation of endogenous H2S seems to be critical for the maintenance of renal homeostasis, through different mechanisms that affect both filtration, endocrine, and metabolic functions of the kidney. This specific spatiotemporal regulation of renal H2S signaling is achieved by regulation of substrate and cofactor availability as well as modulation of the levels, enzymatic activity, and localization of the H2S-producing enzymes. In the kidney, H2S is primarily synthesized by CBS and CSE. While both CBS and CSE are predominantly expressed in proximal tubules [16,17], CSE is also expressed in the glomerulus [18,19]. As compared to CBS and CSE, levels of 3-MST and DAO in the kidney are much lower and their precise role in renal physiology remains unclear [20,21].
In this review, we describe the (sub)cellular and temporal regulation of H2S in the kidney and how H2S exerts its effects within different organelles such as the nucleus, ER, and mitochondria. Moreover, we review how subcellular HS anabolism and catabolism have affected renal(patho)physiology. Next to this, post-translational modification of protein cysteine residues via persulfidation also holds great promise to explain the beneficial properties of H2S with potential relevance for the treatment of renal-related diseases, such as hypertension, ischemia/reperfusion, and acute kidney injury. Therefore, modulation of the levels, enzymatic activity, or localization of H2S-producing enzymes could be pharmacologically exploitable targets to modulate endogenous levels of H2S.
2. Regulation of H2S production
2.1. Subcellular enzyme localization affects spatial specificity of H2S levels
One mode of regulation of H2S signaling specificity consists of the multiple H2S-producing enzymes that have both unique as well as redundant functions. Regulation of H2S production on the organelle level is achieved by (trans)localization of the H2S-producing enzymes in the cell. Natively, CBS and CSE reside mostly in the cytosol, while 3-MST mostly resides in the mitochondrion. The translocation of these enzymes into different organelles allows for subcellular control of H2S levels, as each enzyme has specific cellular localization signals and cues. CBS has a C-terminal mitochondrial targeting sequence which is recognized by Hsp70 under hypoxic conditions, while CSE requires the mitochondrial outer membrane transporter protein Tom20 to translocate to the mitochondrial lumen upon treatment with the ionophore calcimycin [22,23]. Specificity is also achieved by differences in the optimal pH of the H2S synthesizing enzymes. The optimal pH for H2S production by CBS and CSE is pH8.5-9.0 [24,25], which is closer to the slightly alkaline pH of 8.0 within the lumen of the mitochondria as compared to the pH of 7.0-7.4 of the cytosol [26]. The optimal pH for H2S production by3-MST is 7.4 [27], close to the pH of the cytosol. The optimal pH for H>S pre-cursor production by DAOis 8.4 for L-cysteine as a substrate, but7.4 for D-cysteine as a substrate. CBS and CSE is localized primarily in the cytosol, but also in vesicles, nucleoli [28] and mitochondria.3-MST is
Localized in mitochondria [29] and in the cytosol [30]. Finally, DAO -contributes to H2S production via 3-MST-is localized in mitochondria and peroxisomes [21,31]. Together, not only substrate availability, enzyme production, and translocation, but also local pH and substrate-specific pHoptima affect the enzymatic activity and consequently, H2S levels.
2.2. H2S production is regulated through substrate and cofactor availability
Spatiotemporal regulation of H2S is also achieved by modulating substrate availability for H。S production, of which the most important are L-cysteine, L-homocysteine, and 3-mercaptopyruvate, and to a lesser extent i-cystine and D-cysteine [32]. The canonical pathways of H>S synthesis are depicted in Fig. 1, with L-cysteine and L-homocysteine as major substrates for CBS and CSE. The intracellular concentration of L-cysteine is controlled by a number of independent processes: uptake from plasma in endothelial cells, proteolysis (increasing L-cysteine availability), the transsulfuration pathway (L-cysteine as a substrate for H2S synthesis), and the rate of incorporation into glutathione (decreasing or suspending L-cysteine availability)[33]. L-cystine is taken up via the glutamate/cystine antiporter which is under positive control of H2S, which forms a positive feedback loop for H2S production [34]. Dihydrolipoic acid (DHLA)is a potent antioxidant derived from dietary α-lipoic acid (LA), which by reducing L-cystine-was demonstrated to release free L-cysteine [35] to be used for H2S production. The intracellular concentration of L-homocysteine has not been determined yet, possibly because it is a toxic intermediate that is consumed efficiently by CBS, or because the concentration is below the detection limits of current analytical methods. p-cysteine required for DAO comes primarily from the metabolism of nutrients in the gastrointestinal tract [21]. CBS and CSE require the cofactor pyridoxal-5-phosphate (PLP), also known as vitamin B6, to produce H2S.H2S production by 3-MST depending on thioredoxin (Trx) and dihydrolipoic acid: two important redox balance-maintaining molecules[36]. In turn, the expression of Trx is regulated by transcription factors involved in the antioxidant response, such as Nrf2 [37]. The systems that regulate substrate and cofactor availability are complex, with positive and negative feedback loops, and are coupled to the maintenance of the redox balance. Thus, substrate, cofactor availability, and H2S-producing enzyme abundance control HS anabolism.
2.3. H2S clearance is achieved both enzymatically and non-enzymatically
While substrate availability, enzyme levels, and subcellular localization contribute to spatiotemporal regulation of local H>S levels through affecting its synthesis, catabolism, exhalation and excretion regulate lowering of H2S levels. Exhalation accounts for <1% of H>S elimination in the body, as the excretion is the major route responsible for the clearance of HS [38]. Before H2S can be excreted, it first needs to be converted metabolically. Catabolism of H2S occurs both enzymatically and non-enzymatically, of which enzymatic catabolism represents the most important catabolic pathway [3]. In mitochondria, HS is catabolized by the sulfide quinone oxidoreductase system (SQR)to form SQR-bound cysteine persulfides [39,40]. SQR-bound cysteine persulfide is then catabolized into thiosulfate, which is reversible and offers an endogenous donor pool capable of ameliorating hypertensive renal disease and diabetes [41,42]. Furthermore, SQR-bound cysteine per-sulfide is catabolized into sulfite and sulfate that are excreted via urine. H2S is catabolized to sulfite through ethylmalonic encephalopathy 1 protein (ETHE1), which resides in the mitochondrial matrix [43]. Successive methylation of H2S by thiol S-methyltransferase (TMT)and thioether S-methyltransferase(TEMT) forms the trimethyl sulfonium ion, which is also excreted via urine [44]. Lastly, H2S binds to methemoglobin to form sulfhemoglobin in erythrocytes, which act as a sink of H2S upon erythrocyte sequestration to the spleen[45].
2.4. Intermediates of H2S metabolism allow for delayed H2S signaling by storage-and-release
H2S metabolism is not always a one-way street, as certain catabolic intermediates allow for the suspended release of H2S. Three different pools of H2S have been proposed so far: sulfane sulfur species,acid-labile H2S
and polysulfides. First, H2S can be stored in the form of sulfate sulfur species: compounds that contain a sulfur atom with six valence electrons that are bound to another two or more sulfur atoms(RS-Sn-SR)such are: persulfides (RSSH), polythionates(-SO3-Sn-SO3), organic polysulfanes (HSSnSH, RSSS, R, RSSnSH) and thiosulfate(S2O3-/-s-SO3)[5]. H2S from sulfane sulfur compounds can be released in reducing conditions or by the activity of thioredoxin/thioredoxin reductase which is a key player in catabolism or sulfane sulfur, mostly incorporated in protein persulfides [46,47]. The only enzyme reported to produce sulfane sulfur compounds from HS is 3-MST, but the mechanism remains unknown [48,49]. Like HS, sulfane sulfur species also possess strong antioxidant capacities [50], which contributes to the prolonged cytoprotective effect of H2S and sulfane sulfur production by 3-MST. Second, H2S can be stored in the form of acid-labile sulfur that can be released under acidic conditions(pH<5.4), usually in the iron-sulfur center of mitochondrial enzymes [51,52]. Third, H>S can also be stored in the form of poly-sulfides, facilitated by the enzymes 3-MST and cysteine aminotransferase(CAT)[53]. Delayed H2S signaling is achieved through release from H2S pools under specific redox conditions. Together, H2S anabolism is tightly controlled by enzyme localization, substrate specificity, and optimal pH levels, while enzymatic and non-enzymatic metabolism of H2S leads to functional intermediates and ultimately, excretion of H2S derivatives.
2.5. H2S signaling in renal physiology
2.5.1. Vasoactive effects of H2S affect systemic blood pressure and renal blood flow
Production of HS in endothelial cells governs hormetic (i.e. biphasic) dose-dependent vasoactive effects by influencing endothelial and vasomotor function. Endogenous H2S in endothelial cells is produced by CSE[54], 3-MST[55], and CBS [56] and leads to endogenous concentrations of H2S in arterial blood in the range of 0.1-1.0 μM【57，58]. In short-term experiments, exogenous NaHS administration induces vasodilation in isolated human mesenteric arteries and rat thoracic aorta [59,60]. In rats, a bolus injection of H2S transiently decreased blood pressure, indicating vasodilation. In CSE knockout mice, increased blood pressure as compared to wild-type mice was observed, indicating a lack of H2S-mediated vasodilation [54]. On the contrary, results from a recent study have shown the absence of H2S-mediated hypertension in CSE-/mice as well as the increased level of endogenous NO compared to the CSE wildtype animals. This observation emphasizes the direct chemical reaction between H2S and NOWHERE NO reacts with H2S as well as their mutual contribution in the regulation of vascular tone [61].
Administration of a NaHS, an H2S donor in vivo resulted in increased blood pressure at 10 μmolkg-'min-1， while 25 μmol kg-Imin-1 NaHS led to a decrease in blood pressure [62]. This demonstrates the hormetic effects of H2S, conceivably through inhibition of endothelial NO synthase [62].
The tubular function is regulated by H2S through modulation of the renal blood flow(RBF)and consequently, glomerular filtration rate (GFR). An increase in tubular H2S levels stimulates diuresis, natriuresis, and kaliuresis by inhibiting the Na*/K'/2Cl cotransporter (NKCC) in chronically salt-loaded rats [63,64]. Both the HS donor NaHS and the H, S precursor L-cysteine increase GFR in a dose-dependent manner in rats, which was abolished by concomitant inhibition of CBS and CSE. Inhibition of both CBS and CSE alone (by AOAA and PPG, respectively)results in decreased HS levels and a decrease in tubular function [63]. Interestingly, in mice with acute bilateral renal ischemia, the addition of NaHS accelerated regeneration of damaged tubular cells, while administrating PPG slowed their regeneration [65]. Hence, the generation of endogenous H2S in renal endothelial cells leads to reduced blood pressure, while increasing glomerular filtration rate and tubular function.
2.5.2. Modulation of gene expression by H2S is relevant for blood pressure regulation
The spontaneously hypertensive rat (SHR) model was developed by selectively breeding naturally hypertensive rats [66]. The onset of hypertension is associated with decreased CSE activity in arteries, as demonstrated in the thoracic aorta [67]. Further, plasma levels of HS are reduced prior to the onset of hypertension, while administration of NaHS (partially) precludes the onset of hypertension [68]. As low levels of endogenous H2S induce vasodilation and the lack of CSE is associated with hypertension in mice, it is likely that the reduced levels of H2S play a role in the pathophysiology of hypertension in the SHR model. In addition, administration of NaHS in the SHR model downregulates the expression of important components of the RAS system, including renin (Ren), angiotensinogen (Agt), angiotensin-converting enzyme (ace), and angiotensin II receptor, type 1a (Agtrla) to levels below those observed in normotensive control rats [69]. Similarly, administration of NaHS downregulates Ren expression and reduces plasma renin levels in the two-kidneys-one-clip (2K1C) rat model for hypertension [70]. In the 2K1Crat model, hypertension is induced by temporarily restricting blood flow to one kidney, which activates the renin-angiotensin axis and induces hypertension [71].In a mouse model of hypertension induced by treatment with angiotensin II, reduced levels of miR-129 (an epigenetic regulator) are associated with an inflammatory response [72]. Treatment with GYY4137 (an H2S releasing molecule)restored miR-129 expression to normal, thereby mitigating renal inflammation. Potentially, gene expression changes are governed by epigenetic regulation by H2S. Maternal hypertensive rats treated with NaHS produce offspring with increased methylation of the Agtrlb (angiotensin I receptor, type 1b)and decreased levels of the angiotensin II receptor AT1R [73]. Thus, H2S affects the expression of genes (for example Ren, Agt, and Agtrla) that play essential roles in blood pressure regulation, which is potentially mediated through epigenetic regulation, as well as miRNA expression.
2.5.3. H2S protects against kidney injury via protein persulfidation
Persulfidation, also known as"S-sulfhydration", represents the oxidative modification of a cysteine sulfhydryl group where another thiol moiety (originating from H2S, H2S donors, or another persulfide) is covalently attached to the corresponding cysteine sulfhydryl group ultimately forming the persulfide [5,74](Fig.2). Persulfidation modifies protein function and alters protein-protein interactions. First, persulfidation can either increase or decrease the function and activity of target proteins. Persulfidation of cysteine residue C150 of mitochondrial glyceraldehyde 3-phosphate dehydrogenase (GAPDHD, increases its enzymatic activity [74], while persulfidation on C156 or C152leads to a profound decreased activity [75]. Second, persulfidation can also alter protein-protein binding kinetics and thereby protein localization, as is the case in the transcription factor Nrf2. Persulfidation of C150 of cytosolic Keapl initiates dissociation of the bound transcription factor Nrf2 and allows translocation of Nrf2 to the nucleus and enhancement of expression of genes coding for proteins of the antioxidant stress response [76]. Nrf2 has been implicated to protect kidney injury after experimental IR in several studies [77,78]. Finally, persulfidation also protects proteins against detrimental post-translational modifications, such as S-nitrosylation or oxidation during nitrosative and/or oxidative stress conditions [79]. Persulfidation mostly occurs on protein cysteine residues, protecting this moiety from being oxidized by ROS, thus protecting protein function. S-nitrosylation of GAPDH at the aforementioned C150 nullifies enzymatic activity, leading to a marked decrease in ATP production [80]. By persulfidation of GAPDH, but also ATP5a, H2S can rescue ATP production. It is known that in AKI, maintaining ATP production is crucial for the proper recovery of renal function [81]. Together, H2S safeguards renal function after injury through protein persulfidation (see Fig. 3).
2.5.4. H2S modulates redox homeostasis, sodium excretion, and blood pressure through protein persulfidation
In the kidney, the persulfidation of proteins regulates blood pressure and renal sodium handling. Persulfidation of the endothelial growth factor receptor (EGFR)cysteine residues C797/C798 induces endocytosis of the Nat/K+-ATPase, resulting in loss of function of the Na+/K+-ATPase in renal tubular epithelial cells [64]. Through these mechanisms, H2S induces water and sodium excretion in rats, decreasing blood pressure [64]. Further, persulfidation of the angiotensin II receptor, AT1R, by NaHS or L-cysteine attenuates hypertension in angiotensin I-induced hypertensive mice [82]. Thus, protein persulfidation induced by H2S influences protein activity, but can also modulate gene expression by affecting protein-protein interactions and expression of miRNAs. The net effect of these layers of signaling are unclear but are imperative in maintaining redox homeostasis as well as regulation of renal sodium handling and blood pressure.
2.5.5. HS maintains cellular homeostasis upon proteotoxic stress by modulating autophagy
Misfolded proteins are potentially toxic through ER stress and excessive cell death, as is the case in acute kidney injury [83]. Damaged organelles and misfolded proteins are cleared by (macro)autophagy, which is modulated by H2S. Exogenous H2S (NaHS) inhibits autophagy in neonatal rat cardiomyocytes in an in vitro hypoxia-reoxygenation (HR) model, via PI3K/GSK3β signaling [84] and also in hepatocellular carcinoma (HCC) cells, as illustrated by downregulation of genes in the PI3K/AKT/mTOR pathway[85]. In contrast, in a rat model of ischemia-reperfusion (IR), NaHS addition upregulates genes in the AMPK/mTOR pathway, thereby promoting autophagy and protecting against IR injury [85,86]. It is conceivable that under normal circumstances, H2S signaling keeps the rate of autophagy within physiological bounds, while under the circumstances of severe proteotoxic stress, H2S can highly increase autophagic flux. By protecting cells from IR injury via modulating autophagy, H2S signaling attenuates kidney injury after IR.
2.5.6. H2S attenuates proteotoxic stress through protein persulfidation
The endoplasmic reticulum (ER)is indispensable for synthesis, folding, post-translational modification, and transport of proteins, and is the first line of defense in protein folding defects [87]. In addition to regulating autophagy, H2S can both induce and inhibit proteasomal degradation of proteins to attenuateproteotoxic stress in response to a sustained unfolded protein response(UPR). The proteasome selectively degrades misfolded,ubiquitin-tagged proteins, with Nrf2 as a regulator of the UPR [88,89]. Treatment with Na2S partly rescues ischemia-induced heart failure in wild-type mice, but not in mice lacking Nrf2. Presumably, the effects of Naz are mediated by inducing translocation of Nrf2 after persulfidation of Keapl, as described above [76]. Thus, H>S enhances cardiac proteasome activity and thereby attenuates ER stress with cytoprotective effects [90]. On the other hand, in human umbilical vein endothelial cells (HUVECs), H2S prevents the proteasomal degradation of eNOS via persulfidation of eNOS [91]. Notably, proteotoxic stress upregulates CSE at low concentrations of doxorubicin and H2O, in H9c2 myoblasts, while the expression of CSE decreases upon exposure to higher concentrations of doxorubicin and H2O2. The addition of NaHS, but also N-acetylcysteine (NAC), rescues cell viability and diminishes ROS accumulation through rescuing CSE expression and H2S production [92]. In line with these results, the addition of NaHS reduced proteotoxic stress-induced by formaldehyde in PC12 cells, but also in nucleus pulposus(NP)cells challenged with IL-1β [93]. Thus, H>S is both capable of enhancing the entire proteasomal degradation system, but at the same time prevents specific proteins from being degraded by the very same proteasomal degradation system. Next to modulation autophagy and proteasome activity, H2S reduces proteotoxic stress by upregulation protective signaling routes by persulfidation of specific transcription factors.
2.5.7. H2S attenuates proteotoxic stress by persulfidation of epigenetic modifiers and transcription factors
The addition of NaHS reduces proteotoxic stress and rescues cell viability presumably through upregulation of silent mating type information regulator 2 homolog 1(SIRT-1)[94]. Increased activity of SIRT-1 can occur through persulfidation [95]. An alternative explanation for the increase in SIRT-1 activity is a modification of a transcriptional regulator of SIRT-1. As such, persulfidation of NF-kβ, an upstream transcriptional regulator of SIRT-1 [96] leads to the increased transcriptional activity of NF-kβ and thereby SIRT-1 [97]. Additionally, H2S activates PI3K/Akt, ERK1/2, and ATF4 pathways, for example through persulfidation of proteins in these pathways, which reduces ER stress(Fig.2)[98,99]. Recent studies show that persulfidation of SIRT1 and thereby decreasing its deacetylation activity plays a major role in the regulation of its epigenetic function [95]. Thus, H2S plays an important role in regulating ER function by modulating proteasome activity and inducing protective pathways upon proteotoxic stress by persulfidation of upstream transcription factors and epigenetic modifiers.
Whether H2S alleviates proteotoxic stress by H2S within ER or through other mediators is not precisely known yet. However, results obtained in HeLa cells, mouse liver, and zebrafish using an ER-targeted H2S probe, reveal specific localization of H2S to ER [100]. It remains to be studied whether local levels of H2S within ER are regulated by specific modulation substrate availability or translocation of H2S-producing enzymes into the ER. Interestingly, the different H2S-producing enzymes seem to fulfill different roles in alleviating proteotoxic stress. During thapsigargin-induced ER stress in HEK293 cells, the generation of carbon monoxide(CO)inhibits CBS by binding to its heme group, which lowers cystathionine production. As cystathionine is an inhibitor of CSE function, its depletion causes CSE to produce more H2S to attenuate proteotoxic stress [101]. Collectively, this evidence suggests that H2S is a potent modulator of proteotoxic stress through selective modulation of the proteasome and corresponding protein cysteine residues via persulfidation, leading to the upregulation of protective signaling routes.
2.5.8. H2S attenuates kidney injury by maintaining mitochondrial function
Maintaining ATP production during IR or in AKI is crucial for renal function and recovery. Most ATP is produced by oxidative phosphorylation in mitochondria, with substrates derived from the citric acid cycle to fuel the electron transport chain. Alternatively, H2S can also serve as an electron donor in oxidative phosphorylation. Gobern et al. [102]revealed that HS is a substrate of oxidative phosphorylation at nano-molar concentrations. CBS, CSE, and 3-MST either reside in the mitochondrion or can translocate there under specific conditions, to contribute to ATP production directly [103]. As such, hypoxia triggers CBS translocation to mitochondria [22,104]. Mitochondrial CBS levels increase 6-fold within 1 h of hypoxia [22]. Another consequence of hypoxia is the suppression of oxygen-dependent mitochondrial catabolism (e.g. CoQ-dependent SQR activity) of H2S that leads to the accumulation of H S in cells. This observation was recently demonstrated by using mass spectrometry-based H>S-selective chemical probes in ischemic animal tissue and in the organ preservation model system [105] as well as by using an H2S-sensitive fluorescent sensor in anoxic cell culture [106].
In hypoxia, both CSE and CBS activity are associated with elevated ATP production [104,107]. Blockade of CBS or CSE by AOAA/shRNA or PPG, respectively, abrogates the effects of these enzymes on ATP production [107,108]. Stimulating 3-MST function by adding its substrate 3-mercaptopyruvate, increases intramitochondrial H2S levels and stimulates the production of ATP [29]. Apart from electron donation of H2S, persulfidation of ATP synthase and GAPDH increases their activity, thereby stimulating ATP production. Mice lacking CSE have profoundly lowered levels of ATP synthase and GADPH persulfides, associated with reduced ATP production [74,103]. Thus, H2S can stimulate ATP production by donating electrons and by the persulfidation of enzymes involved in mitochondrial ATP production. Furthermore, H2S reduces cytochrome c very efficiently to stimulate the electron flow through the respiratory chain [106]. The same study shows that both endogenous and exogenously applied H2S were able to induce cytochrome c dependent protein persulfidation that suppresses the apoptotic response by persulfidation of a catalytically active cysteine residue of caspase-9 and inhibiting its pro-apoptotic function. In contrast to low levels of endogenous H2S, administration of exogenous H2S profoundly reduce mitochondrial function by inhibiting cytochrome oxidase(complex IV)through binding to ferric iron (Fe3+), thereby halting aerobic ATP generation at alveolar concentrations of >100 ppm [2]. Presumably, through this mechanism, exposure to a concentration of 80 ppm H2S can (reversibly)suppress metabolic rate and thereby toxicity in mice[109].
Together, while low levels of (endogenous)H2S can stimulate ATP production by donating electrons to the electron transport chain and modulating enzymatic activity, high levels of (exogenous)H2S may exert toxic effects by inhibiting cytochrome c oxidase. Thus, H2S maintains ATP production, crucial for renal function after kidney injury.
2.5.9. H2S stimulates antioxidant production, which dampens ROS-induced inflammation
Upon metabolic stress, H2S can overcome the deleterious effects of mitochondrial dysfunction by stimulating ATP production and exerting antioxidant effects by scavenging free radicals, protecting protein residues from being oxidized through persulfidation, and upregulating antioxidant mechanisms. The oxidative stress induced by H2O2 in Xenopus laevis kidney epithelial cells was abolished by (pre)treatment with NaHS [110]. While H2S directly scavenges free radicals-for example peroxynitrite-to form sulfinyl nitrite (HSNO2), H2S also upregulates important anti-oxidant mechanisms including glutathione, a major antioxidant [111]. H2S reduces extracellular cysteine to cysteine, followed by cellular uptake by the cystine/glutamate antiporter [34]. Further, H2S enhances the activity of r-glutamyl cysteine synthetase (y-GCS), one of the two enzymes required to produce glutathione [112, 113]. The mechanism by which H2S affects they-GCS activity is not entirely clear, however, y-GCS expression and protein levels are not affected by H2S, and likely, post-translation modification by persulfidation accounts for the higher y-GCS activity upon H2S stimulation. Next to scavenging free radicals and upregulating glutathione levels, H2S exerts its protective effects through induction of the antioxidant stress response via Nrf2[14]. Hence, in addition to stimulating ATP production, H2S alleviates the damaging effects of mitochondrial dysfunction by reduction of oxidative stress.
The effects of H2S on mitochondrial function may explain its protective effects against renal IR injury, thereby dampening inflammation and reducing structural damage induced by IR [115]. Mice lacking CSE are more prone to acute kidney injury induced by IR, associated with reduced survival [18]. Expression of inflammatory genes and the release of cytokines are reduced through increased per sulfidation of transcription factors such as NF-kβ in renal IR. Therefore, H2S acts as an anti-oxidant through increasing antioxidant glutathione levels and upregulation of the antioxidant stress response. Interestingly, a recent study has demonstrated the opposite, pro-inflammatory CSE-dependent effects in a mouse model of acute ischemic kidney injury. Here, decreased cellular damage and reduced levels of pro-inflammatory interleukins and cytokines were observed in CSE-7mice [16]. The observed differences in experimental results between similar studies may be partly explained by the difference in the genetic background of the animal species and their corresponding phenotypes.
Finally, oxidative stress not only affects cellular homeostasis and cell survival, it also affects renal sodium handling by oxidizing phosphatase and tensin homolog (PTEN), thereby augmenting the activity of the epithelial sodium channel (ENaC), which facilitates Na+ absorption [117]. The effect of oxidative stress on ENaC is abolished by pretreatment with NaHS [117], potentially by protecting PTEN against oxidation by per sulfidating the protein, similar to how H2S-mediated persulfidation can prevent S-nitrosylation-induced loss of PTEN enzymatic function [l18]. Together, precluding mitochondrial dysfunction (i.e. stimulating ATP generation and lowering oxidative stress) precludes kidney dysfunction and damage induced by oxidative stress.
3. Conclusion
The production of H2S is tightly controlled, both quantitatively as well as spatially by catabolic and anabolic processes. Factors such as substrate availability, protein abundance, local pH, and storage capacity control H2S anabolism, while oxygen concentration, enzymatic and non-enzymatic mechanisms control H2S catabolism. H2S metabolites, such as H2S bound as sulfane sulfur or acid-labile pools of H2S can still exert signaling functions. H2S affects renal blood flow by affecting NO levels and thereby, vascular function, as well as regulation of expression of genes responsible for local and systemic blood pressure and sodium excretion. Regulation of protein production and proteotoxic stress is achieved through modulation of autophagic flux, proteasome activity, clearance of aggregated proteins, and the UPR via H2S signaling, which is relevant to attenuate AKI. H2S is an important antioxidant by directly scavenging free radicals, but moreover, it enhances the cellular antioxidant response by serving as a substrate for glutathione production. By forming protein persulfides, H。S modulates enzymatic activity, but also transcription factor activity by affecting protein-protein interactions in the cytosol, which induces translocation of the transcription factor to the nucleus. Under hypoxic conditions, H2S maintains ATP synthesis by acting as an alternative electron donor. Given the protective effects of H2Supon metabolic stress in the kidney, pharmacological targets of H2S may be exploited to treat hypertension, or avert damage during acute kidney injury, occurring during for example ischemia/reperfusion, renal transplantation, or sepsis.
